Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 2/20 | 0.64 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.64 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.62 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.62 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.62 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.62 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.62 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.62 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.62 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.62 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.62 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.54 |
| ▸ | CNR1 | P21554 | 2/20 | 0.52 |
| ▸ | CNR2 | P34972 | 2/20 | 0.52 |
| ▸ | ADCY6 | O43306 | 1/20 | 0.49 |
| ▸ | ADCY3 | O60266 | 1/20 | 0.49 |
| ▸ | ADCY9 | O60503 | 1/20 | 0.49 |
| ▸ | ADCY5 | O95622 | 1/20 | 0.49 |
| ▸ | ADCY8 | P40145 | 1/20 | 0.49 |
| ▸ | GCGR | P47871 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5018702 | 0.94 | HDAC4 (0.57) | HDAC4HDAC1HDAC8HDAC3HDAC7 | |
| SCHEMBL2748147 | 0.93 | HDAC4 (0.57) | HDAC4HDAC1HDAC8HDAC3HDAC7 | |
| SCHEMBL5018899 | 0.92 | HDAC4 (0.60) | HDAC4HDAC1HDAC8HDAC3HDAC7 | |
| SCHEMBL2749004 | 0.91 | HDAC1 (0.64) | HDAC4HDAC1HDAC8HDAC3HDAC7 | |
| SCHEMBL2749116 | 0.91 | HDAC1 (0.67) | HDAC4HDAC1HDAC8HDAC3HDAC7 | |
| SCHEMBL2747341 | 0.91 | HDAC4 (0.55) | HDAC4HDAC1HDAC8HDAC3HDAC7 | |
| SCHEMBL5018860 | 0.89 | HDAC4 (0.53) | HDAC4HDAC1HDAC8HDAC3HDAC7 | |
| SCHEMBL13365409 | 0.89 | HDAC4 (0.52) | HDAC4HDAC1HDAC8HDAC3HDAC7 | |
| SCHEMBL13290343 | 0.88 | HDAC4 (0.51) | HDAC4HDAC1HDAC8HDAC3HDAC7 | |
| SCHEMBL13365466 | 0.88 | HDAC1 (0.59) | HDAC4HDAC1HDAC8HDAC3HDAC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8268865-B2 | Quaternary alkyl ammonium bacterial efflux pump inhibitors and therapeutic uses thereof | REMPEX PHARMACEUTICALS, INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-20120165276-A1 | QUATERNARY ALKYL AMMONIUM BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF | MPEX PHARMACEUTICALS, INC. (US) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165276-A1 | QUATERNARY ALKYL AMMONIUM BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF | ABCB11, ABCC1, SLC47A1 | HDAC4 470/4885HDAC1 333/4885HDAC8 301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.